Global Infectious Disease In Vitro Diagnostics Market Size to Exceed USD 31.55 Billion by 2035 | CAGR of 2.42%
Category: HealthcareGlobal Infectious Disease In Vitro Diagnostics Market Size to Exceed USD 31.55 Billion by 2035
According to a research report published by Spherical Insights & Consulting, The Global Infectious Disease In Vitro Diagnostics Market Size is expected to Grow from USD 24.25 Billion in 2024 to USD 31.55 Billion by 2035, at a CAGR of 2.42% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 200 pages with 100 Market data tables and figures & charts from the report on the “Global Infectious Disease In Vitro Diagnostics Market Size, Share, and COVID-19 Impact Analysis, By Product (Instruments, Reagents, and Software), By Technology (Immunoassay, Molecular diagnostics, Microbiology, and Others), By Application (MRSA, Streptococcus, Clostridium difficile, VRE, CRE, Respiratory Virus, Candida, COVID-19, and Others), By Test Location (Point of Care, Central Laboratories, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.” Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/infectious-disease-in-vitro-diagnostics-market
The infectious disease in vitro diagnostics market is the market encompassing the development, production, and distribution of diagnostic tools used for detecting infectious diseases. In vitro diagnostics (IVDs) tests may be done on a variety of instruments, ranging from small, handheld tests to complex laboratory instruments. There is an increasing geriatric population susceptible to infectious diseases, along with surging awareness about early detection and demand for PoC testing in the infectious disease in vitro diagnostics market. Development of diagnostic technologies, along with an integration of AI and ML for enhancing diagnostic accuracy and speed, is escalating the market growth opportunities. The concerns regarding the increased prevalence of infectious diseases and the awareness about early detection diagnostics are driving the market. Additionally, a shift towards home testing & telemedicine, as well as the developments in molecular diagnostic techniques contributing to promoting market growth. However, an increased price and stringent regulatory frameworks are challenging the infectious disease in vitro diagnostics market.
The reagents segment accounted for the largest revenue share in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the product, the infectious disease in vitro diagnostics market is divided into instruments, reagents, and software. Among these, the reagents segment accounted for the largest revenue share in 2024 and is projected to grow at a substantial CAGR during the forecast period. An increased adoption of advanced molecular techniques in clinical microbiology labs, along with the growing use of reagents, is propelling the market in the reagents segment.
The immunoassay segment accounted for the largest revenue share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the technology, the infectious disease in vitro diagnostics market is divided into immunoassay, molecular diagnostics, microbiology, and others. Among these, the immunoassay segment accounted for the largest revenue share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The growing focus on the development and commercialization of immunoassays for infectious diseases is bolstering the market growth in the immunoassay segment.
The COVID-19 segment accounted for the largest revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the application, the infectious disease in vitro diagnostics market is divided into MRSA, streptococcus, clostridium difficile, VRE, CRE, respiratory virus, candida, COVID-19, and others. Among these, the COVID-19 segment accounted for the largest revenue share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. An increasing adoption of SARS-CoV-2 testing, with upsurging government initiatives for enhancing public testing, is propelling the market in the COVID-19 segment.
The central laboratories segment accounted for a major share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the test location, the infectious disease in vitro diagnostics market is divided into point of care, central laboratories, and others. Among these, the central laboratories segment accounted for a major share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The growing adoption of outsourcing laboratory services for reducing costs related to research activities is escalating the market in the central laboratories segment.
North America is expected to hold the majority share of the global infectious disease in vitro diagnostics market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global infectious disease in vitro diagnostics market during the forecast period. The growing prevalence of infectious diseases, along with the emergence of cutting-edge technologies contributing to driving the market demand. The presence of robust infrastructure and key market players in the region is also responsible for regional market growth.
Asia Pacific is anticipated to grow at the fastest pace in the global Infectious disease in vitro diagnostics market during the forecast period. An increasing demand for point of care (PoC) testing and rapid diagnostics, with the prevalence of infectious diseases, is driving the market demand. The region’s rapid economic development, with the driving adoption of novel tests for diagnostics, is propelling the market growth.
Europe is anticipated to hold a significant share of the infectious disease in vitro diagnostics market during the projected timeframe. An increasing geriatric population, driving the need for ongoing monitoring owing to the high risk of both chronic infectious diseases, is propelling the market demand. In addition, the emergence of new IVD regulations presenting a more robust and sustainable framework for compliance with the devices is promoting the market growth.
Major vendors in the global infectious disease in vitro diagnostics market are QIAGEN, BD, bioMérieux SA, F. Hoffmann-La Roche, Ltd., Hologic, Inc. (Gen Probe), Abbott, Quidel Corporation, Siemens Healthineers AG, Bio-Rad Laboratories, Inc., Danaher, OraSure Technologies, Inc., and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In December 2024, OraSure Technologies, Inc., a leader in point-of-need and home diagnostic tests and sample management solutions, announced the acquisition of Sherlock Biosciences, Inc., a global health company bringing next-generation diagnostics to consumers and healthcare providers.
- In October 2024, Quest Diagnostics, a leading provider of diagnostic information services, announced that it had been awarded several contracts by the U.S. Centers for Disease Control and Prevention (CDC) to support testing and sustained laboratory readiness.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the infectious disease in vitro diagnostics market based on the below-mentioned segments:
Global Infectious Disease In Vitro Diagnostics Market, By Product
- Instruments
- Reagents
- Software
Global Infectious Disease In Vitro Diagnostics Market, By Technology
- Immunoassay
- Molecular diagnostics
- Microbiology
- Others
Global Infectious Disease In Vitro Diagnostics Market, By Application
- MRSA
- Streptococcus
- Clostridium difficile
- VRE
- CRE
- Respiratory Virus
- Candida
- COVID-19
- Others
Global Infectious Disease In Vitro Diagnostics Market, By Test Location
- Point of Care
- Central Laboratories
- Others
Global Infectious Disease In Vitro Diagnostics Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?